$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
吃普纳替尼可以随意停药吗?
2025-10-19 11:44:20
Check Details
雷德帕斯吃几天起效果?
2025-10-19 11:44:20
Check Details
雷德帕斯胶囊怎么服用?
2025-10-19 11:44:20
Check Details
普纳替尼治疗白血病的效果
2025-10-19 11:44:20
Check Details
雷德帕斯胶囊去哪买?
2025-10-19 11:44:20
Check Details
雷德帕斯吃多久算一个疗程?
2025-10-19 11:44:20
Check Details
雷德帕斯在哪里能买到?
2025-10-19 11:44:20
Check Details
普纳替尼(帕纳替尼)有什么注意事项?
2025-10-19 11:44:20
Check Details
雷德帕斯国内获批上市了吗?
2025-10-19 11:44:20
Check Details
雷德帕斯(米哚妥林)进入医保了吗?
2025-10-19 11:44:20
Check Details
雷德帕斯治疗什么病?
2025-10-19 11:44:20
Check Details
白血病患者服用雷德帕斯治疗的效果
2025-10-19 11:44:20
Check Details
1
2
...
473
474
475
476
477
478
479
...
939
940
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
After Ibrutinib Resistance: CLL/SLL and MCL Next Steps, Progression vs Intolerance
2
Quizartinib for FLT3-ITD AML: Induction-Consolidation-Maintenance and QT Monitoring
3
Ibrutinib for Mantle Cell Lymphoma: BTK Mechanism, Response Is Not Cure, Post-Resistance Options
4
In-Depth Analysis of Selinexor (Xpovio): A Novel Nuclear Export Blockade Option for Relapsed/Refractory Multiple Myeloma and Latest Clinical Advances
5
Acalabrutinib BTK Covalent Inhibition: CLL/SLL Signaling Blockade, Non-Selective Effects, and Progression Monitoring
6
Bosutinib for Ph+ CML: Eligible Populations, Food-Dependent Dosing, Diarrhea and Hepatotoxicity Monitoring
7
Venetoclax BCL-2 Inhibitor: CLL/SLL and AML Ramp-Up, Tumor Lysis Prevention, and Selected Overseas Combination Updates
8
First-Line Pirtobrutinib Without 17p Deletion in CLL/SLL: Noncovalent BTK vs BR, Median PFS Not Reached, HR 0.20
9
Belumosudil for cGVHD: 200mg with Food, Pregnancy Contraception, Liver Monitoring, Drug Interactions
10
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
11
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
12
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments